Mesenchymal stem cells induce expression of cD73 in human monocytes in vitro and in a swine model of myocardial infarction in vivo

The ectoenzymes CD39 and CD73 regulate the purinergic signaling through the hydrolysis of adenosine triphosphate (ATP)/ADP to AMP and to adenosine (Ado), respectively. This shifts the pro-inflammatory milieu induced by extracellular ATP to the anti- inflammatory regulation by Ado. Mesenchymal stem c...

ver descrição completa

Detalhes bibliográficos
Autores: Monguió-Tortajada, Marta|||0000-0003-2125-0810, Rudilla, F.., Gálvez-Montón, Carolina|||0000-0003-2254-9371, Franquesa, Marcella|||0000-0002-1287-8908, Bayés-Genís, Antoni|||0000-0002-3044-197X, Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
Formato: artículo
Fecha de publicación:2017
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:196945
Acesso em linha:https://ddd.uab.cat/record/196945
https://dx.doi.org/urn:doi:10.3389/fimmu.2017.01577
Access Level:acceso abierto
Palavra-chave:CD73
Adenosine
Immunomodulation
Mesenchymal stem cell
Ectonucleotidase
Myocardial infarction
Purigernic signaling
Regeneration
Descrição
Resumo:The ectoenzymes CD39 and CD73 regulate the purinergic signaling through the hydrolysis of adenosine triphosphate (ATP)/ADP to AMP and to adenosine (Ado), respectively. This shifts the pro-inflammatory milieu induced by extracellular ATP to the anti- inflammatory regulation by Ado. Mesenchymal stem cells (MSCs) have potent immunomodulatory capabilities, including monocyte modulation toward an anti-inflammatory phenotype aiding tissue repair. In vitro, we observed that human cardiac adipose tissue-derived MSCs (cATMSCs) and umbilical cord MSCs similarly polarize monocytes toward a regulatory M2 phenotype, which maintained the expression of CD39 and induced expression of CD73 in a cell contact dependent fashion, correlating with increased functional activity. In addition, the local treatment with porcine cATMSCs using an engineered bioactive graft promoted the in vivo CD73 expression on host monocytes in a swine model of myocardial infarction. Our results suggest the upregulation of ectonucleotidases on MSC-conditioned monocytes as an effective mechanism to amplify the long-lasting immunomodulatory and healing effects of MSCs delivery.